Abstract: Neuropeptide Y (NPY), a 36-mer neuromodulator, binds to the receptors Y 1 , Y 2 , Y 4 and Y 5 with nanomolar affinity. They all belong to the rhodopsin-like G-protein coupled, seven transmembrane helix spanning receptors. In this study, Ala-substituted and centrally truncated NPY analogues were compared with respect to affinity to the Yreceptors. Furthermore, antibodies against the second (E2) and the third (E3) extracellular loop of NPY Y 1 -, Y 2 -and Y 5 -receptor subtypes were raised and affinity to intact cells was tested by immunofluorescence assays. Both methods were applied in order to receive subtype selective tools and to characterise ligand binding. 
Introduction
Neuropeptide Y (NPY) is a 36 amino acid peptide hormone that belongs to the pancreatic polypeptide hormone family [1] . It is widely distributed both peripherally and centrally. Similar to many other neurotransmitters, NPY elicits diverse physiological effects. One of the most striking actions of NPY is the stimulation of food intake in a variety of vertebrate species [2] . But also various other biological effects have been attributed to NPY, e.g., profound effects on secretion of luteinising hormone as well as on growth hormone and insulin release [3] [4] [5] . These observations suggest the important role of NPY in the pathophysiology of obesity and diabetes. Furthermore, it has been reported that NPY elicits potent vasoconstriction [6] , facilitates learning and memory retention processes [7] , modulates locomotor behaviours [8] , produces hypothermia [9, 10] , inhibits sexual behaviour [11] , shifts the circadian rhythms [12] , modulates cardiorespiratory parameters [13] , generates anxiolytic effects [14] , and inhibits alcohol consumption and resistance [15] . Accordingly, NPY is a neuronal and endocrine messenger that exerts its effects via several receptor subtypes. Five distinct NPY receptor subtypes have been cloned and pharmacologically characterised [16] . They are named Y 1 - [17] [18] [19] , Y 2 - [20] [21] [22] , Y 4 /PP 1 - [23, 24] , Y 5 - [25] and y 6 - [26] receptor subtypes. All subtypes belong to the large superfamily of the G-protein-coupled, heptahelical receptors [27] . The different receptor subtypes are localised in various tissues, in the central nervous system as well as in the periphery. Tissues with high density of NPY receptors are blood vessels, kidney, adrenal glands, colon, heart, pancreas, intestine, nerve endings and brain [2] . The broad physiological relevance of NPY gives reason for an increasing interest in NPY as a new target in drug discovery.
It is not yet fully understood which NPY receptor subtype is related to a certain physiological effect. Available evidence suggests for example that the Y 1 -or Y 5 -receptor or even both receptors together regulate the food intake behaviour [2] . Furthermore, the receptor subtypes are distributed heterogeneously in various tissues. Therefore, receptor subtype selective tools are very important for understanding the biological role and distribution of the receptors and can provide important knowledge for drug design.
Each receptor subtype recognises specific parts of the hormone folded in an unique conformation. Thus, different receptor subtypes can be characterised by selectively increasing the affinity/activity of peptide analogues in cells or tissue [28] . Generally, full length analogues are obtained by D-amino acid-or L-alanine-scan or by further amino acid replacements [29] . Frequently, the native ligands are shortened by deletion of the C-or N-terminal parts, or by central truncation [30] . Moreover, analogues with agonistic or antagonistic activity can be a powerful tool to investigate the biological function of a receptor subtype.
Antibodies produced against hormone receptors are valuable tools for investigating the receptor localisation on cells or tissue, regulation and desensitisation [31] [32] [33] [34] [35] [36] [37] . Anti-receptor antisera can be raised by immunisation with purified, enriched receptors [33] or by immunisation with receptor fragments [32] [33] [34] [35] . Antibodies specifically recognising the NPY receptor subtypes can be used to determine either the localisation pattern and the quality of the receptor protein expression or the topology and function of a receptor subtype [38] .
In this study we describe synthetic NPY analogues tested in binding assays against the Y-receptors and we compare the binding of antibodies raised against the second and the third extracellular loop of NPY Y 1 -, Y 2 -and Y 5 -receptor subtypes to intact cells in immunofluorescence assays. Both methods are applied in order to get subtype selectivity and to obtain tools to localise the different receptor subtypes (Table 1) .
Results and Discussion

Synthesis of the Analogues and Receptor Segments
All peptides were designed as amino acid mono-substituted full length or centrally truncated analogues of pNPY and hPP and were obtained by multiple automatic solid phase peptide synthesis using the Fmoc strategy.
The size of the receptor segment peptides ranged between 19 and 20 amino acids, in order to increase the probability that the peptides fold into an ordered structure. The peptides were characterised by analytical HPLC and electrospray ionization mass spectrometry.
Table 1
Sequence and analytical data of the peptides used to generate anti-receptor antibodies. The peptides are named according to the receptor and the loop from which they were derived. Position in the receptor
Name
a At the position 93 the natural amino acid Cys was substituted by Phe.
Characterisation of the Sera
The total absorption (405 nm) of the antibodies tested against the peptides ranged from 0.15 to 0. 45 . The values of preimmune sera ranged from 0.10 to 0.36. They were subtracted from the total absorption to obtain specific binding. The blank values were under 0.05. All antisera showed specific binding.
Binding Potency of Full Length NPY Analogues
The affinity to the receptors Y 1 and Y 2 of all 36 Ala-substituted analogues of NPY has been reported previously [40] . In the present work, we have considered sixteen selected Ala-substituted NPY analogues and investigated their binding affinity additionally at the human receptors Y 4 and Y 5 . Y 1 -and Y 2 -receptor binding data are listed for comparison ( Table 2 ). The substitution of Pro at the positions 2, 5, 8 and 13 led in general to a decreased affinity. In particular, the substitution of the residues 2 and 5 reduced the hY 1 -receptor affinity about 500-and 1000-fold, respectively; the substitution of Pro 5 decreased the hY 2 -receptor affinity 600-fold, and the replacement of Pro 8 led to a 11-and 69-fold lower affinity at the hY 4 -and hY 5 -receptor subtypes, respectively. By single exchange of any of the aromatic side chains of the Tyr residues, the positions 27 and 36 resulted to be the most important for the binding at the hY 1 -receptor, with a loss of affinity of 1000-and 4200-fold after substitution, respectively, whereas the presence of Ala 20 was characterised by a 300-fold reduced affinity at this receptor. The binding at the hY 2 11 , we could obtain a slightly more potent ligand at the receptors hY 4 and hY 5 , whereas the potency at the other two subtypes decreased slightly (35-and 5-fold at the hY 1 -and hY 2 -receptor subtypes, respectively). The decrease in hydrophilicity at the position 32 by substitution of Thr with Ala also led to a decreased affinity, especially at the hY 1 -receptor (> 3000-fold) and hY 2 -receptor (> 1000-fold). These two receptors were also the most sensitive to the substitution of Gln 34 , while the binding at the receptors hY 4 and hY 5 remained almost as good as for the native ligand. Moreover, the analogue [Leu 34 ]-pNPY could bind the hY 4 -receptor 18-fold more potently than pNPY itself. Instead, the presence of D-Pro 34 considerably reduced the affinity at all receptor subtypes, whereas it was previously reported that L-Pro at the same position was perfectly tolerated at the receptors hY 1 , hY 4 and hY 5 , but not at the hY 2 -receptor [25] . IC 50 values of the full length NPY analogues are summarised in Table 2 .
TABLE 2
Analytical (top) and biological (bottom) data of amino acid mono-substituted and centrally truncated NPY analogues. In brackets the affinity of the peptide divided by the affinity of pNPY is given.
Peptide Mass calc .
[Da] 
[Ahx [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] ]-hPP >500 (>2174) >1000 (>25000) 144 (26) >1000 (>1250)
[Ahx [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ]-hPP >1500 (>6522) >1000 (>25000) 216
Binding Potency of Centrally Truncated NPY Analogues
The central segment of pNPY was suggested to be important for the peptide conformation and to adopt a turn-like structure that induces the molecule to fold like a hairpin [41] . This was investigated by the preparation of pNPY analogues, where the central region was removed and substituded by a spacer like 6-amino hexanoic acid (Ahx) [42] . By varying the cutting position either at the N-or the Cterminus, it was found that the analogue [Ahx [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] ]-pNPY could selectively bind to the hY 2 -receptor with 1.4 nM affinity (Table 2) . Furthermore, analogues with longer N-and C-terminal fragments showed similar affinity at the hY 1 -receptor but also significant affinity at the receptors hY 4 and hY 5 . Among these analogues, the one with the highest number of residues at the N-and C-termina, [Ahx [9] [10] [11] [12] [13] [14] [15] [16] [17] ]-pNPY, was the most potent ligand (13 nM at the hY 1 , 45 nM at the hY 4 and 11 nM at the hY 5 ). Accordingly, the residues 9 to 18 are not of major importance for receptor affinity. Three centrally truncated analogues of hPP were also investigated for binding to the Y-receptors. The ligands containing the Ahx moiety instead of the middle segments 5-24 and 5-20 did not show any affinity at the hY 1 -and hY 5 -receptor subtypes, and their affinity to the hY 4 -receptor was considerably reduced. Interestingly, the analogue [Tyr [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ]-hPP was found to selectively bind the hY 4 -receptor, however with a 670-fold reduced affinity. IC 50 values of the centrally truncated NPY analogues are summarised in Table 2 .
Immunofluorescence on Cells expressing Y-Receptor Subtypes
Immunofluorescence experiments were performed in order to determine the selectivity of the antibodies for the Y-receptors on receptor expressing SK-N-MC cells (neuroblastoma, hY 1 ), SMS-KAN cells (neuroblastoma, hY 2 ) and BHK cells (baby hamster kidney cells, rY 5 ). For positive control, cells were directly incubated with goat anti-rabbit FITC coupled IgG. Negative control was made with preimmune sera and by preincubation of the anti-receptor antisera with the corresponding antigen peptide to block specific binding (Figure 1 B) . 6 . Accordingly, selectivity is a major problem. Furthermore, because of the different effects and the distribution of the receptor, it is of major importance to develop tools that allow the characterisation of the receptors on the protein level. Selective ligands, for example radiolabelled-, fluorescent-labelled-and anti-receptor-antibodies are approaches to address this issue. Furthermore, we were interested in the molecular characterisation of the binding site. Again, ligands with specific replacements [43] and anti-receptor antibodies [44] have been used to map ligand binding. Accordingly, we used both approaches and applied them to the NPY/PP system: on the one hand, full length and centrally truncated NPY analogues were synthesised and their binding potency at the NPY receptor subtypes was tested. On the other hand, polyclonal antibodies raised against synthetic receptor fragments on the second (E2) and third (E3) extracellular loop of the receptor subtypes were tested on intact cells expressing NPY receptors. The receptor binding properties of the pNPY and hPP analogues presented in this work showed how the affinity of the native ligand at its receptor subtypes can be modulated by modifying its primary structure that is likely to change, consequently, its spatial conformation. It has been supposed that the members of the PP-family adopt a hairpin-like structure which is stabilised by the interdigitation of the tyrosine side chains on the surface of the C-terminal amphipatic α-helix with the proline residues of the N-terminus. Accordingly, all NPY receptors have been shown to be sensitive to the positions of Pro To investigate the receptor binding site, also anti-receptor antibodies are useful tools. If the antibodies are obtained against receptor fragments, then the localisation of the functional groups will be possible by competition studies with the ligand. For the Y 1 -receptor this method has been described by Wieland et al. [44] . In the present work, only a few sera for every receptor subtype were generated. To map the binding site with competition experiments, more sera for every receptor subtype are necessary.
To obtain antibodies which can be used to characterise intact cells, we prepared peptides based on the extracellular loops of the receptors for immunisation. The extracellular loops of the NPY receptors show some similarity, which makes it difficult to achieve full subtype selectivity, which furthermore is difficult to predict. Nevertheless, the generated sera have been shown to be precious tools. For the sera Y 1 E2/2 and Y 5 E2/2, subtype selectivity for the Y 1 -and Y 5 -receptor subtypes was achieved. The sera Y 5 E2/2 and Y 5 E3 bound equally well to the Y 5 -and the Y 2 -receptor subtypes. In combination, these sera are able to distinguish between the receptors Y 1 , Y 2 and Y 5 . Detection of binding is easy and reliable with a second fluorescent-labelled antibody that is directed against the immunglobulin of the first species. Antibodies also allow receptor localisation investigations in tissue, which is important for the understanding of the physiological effect and of the biological role of a receptor subtype. Moreover, antibodies raised against receptor fragments can be used for many other applications, like molecular mass determination of the receptor protein, affinity purification, receptor regulation, desensitisation and localisation of functional groups [45] .
For both NPY analogues and anti NPY receptor antibodies, a rational approach to achieve subtype selectivity is difficult. Ligand-receptor interaction is usually not fully understood for every receptor subtype, which makes prediction of selectivity very hard. Because of sequence similarity amongst receptor subtypes, it is not easy to choose receptor fragments for immunisation that will not lead to any cross-reactivity. Furthermore, the peptides for immunisation may not be too small, in order to obtain the same secondary structure of the segment as in the receptor.
Production of NPY analogues in comparison to antibodies is fast and cheap, but fluorescent labelling of the analogues can influence their binding to the receptor, whereas anti-receptor antibodies can be detected with a secondary, labelled antibody. Furthermore, binding of small peptides on cells or tissue can be difficult to test, because they can be washed out during experimental procedure.
Conclusions
The goal of this work was the comparison of selective NPY analogues and anti-receptor antibodies with respect to subtype selectivity and mapping of the binding. For both methods this was partly achieved. The analogues and the antibodies are very good tools to distinguish NPY receptor subtypes on membranes and intact cells. The design and synthesis of new ligands is usually a successful approach to characterise different receptor subtypes conformationally and biologically. In fact, by means of selective analogues it is possible to better understand how each receptor interacts with the ligand and also through which subtype the hormone modulates some physiological functions. Furthermore, these insights are essential for the modelling and the development of new potent drugs, based on a rational design.
In a next step, the analogues and the antibodies have to be tested on tissue because knowledge of receptor distribution is important for the understanding of the physiological and biological role of a receptor subtype. Furthermore, localisation studies should be performed also on the protein level, since mRNA localisation does not fit necessarily with the localisation of the mature protein, as suggested by the observation of the rapid axonal transport for the Y 1 -receptor [46] .
The NPY analogues and the peptides for immunisation were synthesised by automated multiple solid phase peptide synthesis using a robot system (Syro, MultiSynTech, Bochum, Germany). In order to obtain the C-terminally amidated peptides, the chain assembly was performed on a 0.015 mmol scale using 4-(2´,4´-dimethoxyphenyl-Fmoc-aminomethyl)-phenoxy resin (Novabiochem, Läufelfingen, Switzerland) and Fmoc/tert-butyl chemistry. The side chain protection of the Fmocamino acids (Alexis, Läufelfingen, Switzerland) was chosen as follows: Trt for Asn, Gln and His, tertbutyl for Asp, Glu, Ser, Thr and Tyr, Boc for Lys and Trp, and 2,2,5,7,8-pentamethylchroman-6-sulfonyl for Arg. A double coupling procedure was performed with diisopropylcarbodiimide/1-hydroxy-benzotriazole (Fluka, Buchs, Switzerland) activation, 7-fold excess and a coupling time of 40 min. Fmoc removal was accomplished by 30% piperidine (Fluka) in DMF for 15 min. The peptide amides were simultaneously cleaved from the resin and deprotected with TFA/thioanisole/thiocresol (Fluka) for 2.5 hours, and collected by precipitation from diethyl ether.
The peptides were purified by preparative HPLC and characterised by analytical HPLC on nucleolsil C-18 column, 5 µm, 3 x 125 mm (Merck-Hitachi, Darmstadt, Germany). The elution system was 0.1% TFA in acetonitrile (Scharlau, Barcelona, Spain) (A) and 0.1% TFA in water (B); a gradient of 15-60 % A or 25-75 % A over 30 min was used. Correct mass was identified by electrospray ionization mass spectrometry (SSQ710, Finnigan, San Jose, CA). The sequence and the chemical characterisation of the peptides are summarised in Tables 1 and 2 .
Preparation of the Conjugates and Immunisation
For the immunisation the peptides were coupled to keyhole limpet hemocyanin (KLH) (Biotrend, Cologne, Germany). Polyclonal antibodies against the KLH-coupled receptor fragments were obtained by immunisation of rabbits (Biotrend, Cologne, Germany).
Titer Determination of the Receptor Segment Peptides
In order to determine the titer of the antibodies raised against the peptide-KLH conjugates, the peptides were covalently coupled to preactivated ELISA plates (Life Technologies, Basel, Switzerland). The antibody solutions were diluted and incubated at 37 °C for 90 min. The plates were washed 4 times and the secondary antibody was incubated for 1 hour. After washing the plates 4 times, staining was carried out with 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) and the absorption was subsequently measured at 405 nm in an ELISA-reader. 4 , rY 5 and hY 5 ) were cultivated in DMEM (Life Technologies) supplemented with 10% (v/v) fetal calf serum, 1% (v/v) antibiotic-fungicide solution (penicilin 10000 U/ml, streptomycin 10 mg/ml and fungizone 25 µg/ml; AMIMED) and 1 mg/ml geneticin (G418; SIGMA, Buchs, Switzerland). Additionally, 1 mg/ml Hygromicin and 24 hours before harvest 1 mM IPTG was added to the rY 4 expressing BHK cells. Cells were maintained at 37 °C in a humidified atmosphere containing 5% CO 2 and 95% air in 75 cm 2 flasks (Techno Plastic-Products AG, Trasadingen, Switzerland). They were harvested at 100% confluency in phosphate buffered saline (PBS; Life Technologies) containing 0.02% EDTA.
Binding Potency of NPY Analogues
Membrane suspensions obtained from SK-N-MC (hY 1 ), SMS-KAN (hY 2 ) and BHK (r/hY 4 , r/hY 5 ) cells (100 µl) were prepared as described previously [28, 30] 
